Newsletter - May 4, 2023
FDA Advises When to Do or Not Do Decentralized Clinical Trials
During the pandemic, completely or partially decentralized clinical trials (DCTs) became the only way clinical trials could be conducted reasonably, where possible. Although the dire necessity for DCTs is no longer there, their utility in increasing trial accessibility to a wider patient pool cannot be denied. Read More
NIH-Funded Animal Research Without Ethical Compliance in Columbia
The recent allegations of a NIH-funded researcher in Columbia conducting primate studies without proper ethics approval and conduct non-compliant with good laboratory practices (GLP) for non-clinical research have sparked outrage in the scientific community and raised important questions about the ethical standards...Read More
FDA Advises When to Do or Not Do Decentralized Clinical Trials
During the pandemic, completely or partially decentralized clinical trials (DCTs) became the only way clinical trials could be conducted reasonably, where possible. Although the dire necessity for DCTs is no longer there, their utility in increasing trial accessibility to a wider patient pool cannot be denied. Read More
NIH-Funded Animal Research Without Ethical Compliance in Columbia
The recent allegations of a NIH-funded researcher in Columbia conducting primate studies without proper ethics approval and conduct non-compliant with good laboratory practices (GLP) for non-clinical research have sparked outrage in the scientific community and raised important questions about the ethical standards...Read More